Literature DB >> 20154285

Platelet count and prothrombin time help distinguish thrombotic thrombocytopenic purpura-hemolytic uremic syndrome from disseminated intravascular coagulation in adults.

Yara A Park1, Michael R Waldrum, Marisa B Marques.   

Abstract

Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) and disseminated intravascular coagulation (DIC) may have identical manifestations in adults. Because TTP-HUS is 90% fatal without plasma exchange, prompt diagnosis is essential. To test the hypothesis that routine laboratory assays can discriminate between the 2 entities, we retrospectively identified adult patients with TTP-HUS and matched each with 2 patients with DIC. Although the platelet count, prothrombin time (PT), and partial thromboplastin time were different (P < .05) between the 2 patient groups, after regression analysis, only PT and profound thrombocytopenia remained associated with TTP-HUS (P = .001 and P = .003, respectively). A platelet count of less than 20 x 10(3)/microL (20 x 10(9)/L) and a PT within 5 seconds of the upper limit of the reference interval had a specificity of 92% for TTP-HUS. Our data confirm that readily available laboratory assays in the proper clinical scenario can increase the likelihood of TTP-HUS over DIC.

Entities:  

Mesh:

Year:  2010        PMID: 20154285     DOI: 10.1309/AJCPPNF63FLIORCI

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  10 in total

Review 1.  The loss of homeostasis in hemostasis: new approaches in treating and understanding acute disseminated intravascular coagulation in critically ill patients.

Authors:  Karen M Hook; Charles S Abrams
Journal:  Clin Transl Sci       Date:  2011-12-07       Impact factor: 4.689

2.  [Clinical course and differential diagnosis of thrombotic microangiopathy].

Authors:  M Guthoff; N Heyne
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-07-12       Impact factor: 0.840

3.  Attending rounds: microangiopathic hemolytic anemia with renal insufficiency.

Authors:  William F Clark; Ainslie Hildebrand
Journal:  Clin J Am Soc Nephrol       Date:  2011-12-22       Impact factor: 8.237

4.  Quetiapine-induced thrombotic microangiopathy in a patient on maintenance dialysis.

Authors:  Miki Takahashi; Akihito Deguchi; Hiromu Nishihara; Mea Asou; Tomohiko Asakawa; Makoto Araki
Journal:  CEN Case Rep       Date:  2020-09-27

Review 5.  Thrombotic microangiopathy and associated renal disorders.

Authors:  Thomas Barbour; Sally Johnson; Solomon Cohney; Peter Hughes
Journal:  Nephrol Dial Transplant       Date:  2012-07       Impact factor: 5.992

6.  A non-invasive laboratory panel as a diagnostic and prognostic biomarker for thrombotic microangiopathy: development and application in a Chinese cohort study.

Authors:  Tao Zhang; Huimei Chen; Shaoshan Liang; Dacheng Chen; Chunxia Zheng; Caihong Zeng; Haitao Zhang; Zhihong Liu
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

7.  Acute Respiratory Distress Syndrome as an Organ Phenotype of Vascular Microthrombotic Disease: Based on Hemostatic Theory and Endothelial Molecular Pathogenesis.

Authors:  Jae C Chang
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

8.  Acute renal failure as the presenting sign of disseminated intravascular coagulation in a patient with metastatic prostate cancer.

Authors:  Ryuji Ohashi; Yusuke Hosokawa; Go Kimura; Yukihiro Kondo; Keiji Tanaka; Shinichi Tsuchiya
Journal:  Int J Nephrol Renovasc Dis       Date:  2013-03-06

9.  Renal thrombotic microangiopathy in a patient with septic disseminated intravascular coagulation.

Authors:  Yusuke Sakamaki; Konosuke Konishi; Koichi Hayashi; Akinori Hashiguchi; Matsuhiko Hayashi; Eiji Kubota; Takao Saruta; Hiroshi Itoh
Journal:  BMC Nephrol       Date:  2013-11-27       Impact factor: 2.388

10.  Hemolytic Uremic Syndrome: An Increasingly Recognized Public Health Problem.

Authors:  Takuya Murakami; Tetsu Akimoto; Tomoyuki Yamazaki; Hiromichi Yoshizawa; Mari Okada; Atsushi Miki; Saki Nakagawa; Ken Ohara; Taro Sugase; Takahiro Masuda; Takahisa Kobayashi; Osamu Saito; Shigeaki Muto; Daisuke Nagata
Journal:  Clin Med Insights Case Rep       Date:  2018-07-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.